The patient’s clinical characteristics and the results of noninvasive testing are used to identify patients likely to benefit from coronary angiography followed by revascularization of appropriate lesions. In patients with chronic coronary syndrome (CCS), also referred to as stable ischemic heart disease (SIHD), there are two primary indications for this: ● Angina that significantly interferes with a patient's lifestyle despite maximal tolerable medical therapy. ● Patients with clinical characteristics and results of noninvasive testing that indicate a high likelihood of severe ischemic heart disease (eg, imaging or strongly positive treadmill test suggesting a large amount of viable myocardium at risk). Additionally, patients with depressed left ventricular systolic function (ejection fraction <50 percent) and moderate risk criteria on noninvasive testing with demonstrable ischemia may benefit from coronary angiography. REF. UpToDate 2020.12.06 |
'심장내과 > 협심증' 카테고리의 다른 글
항협심증 약물 : (1) 베타차단제 [문정역 내과] (0) | 2021.02.01 |
---|---|
Chronic coronary syndrome [stable ischemic heart disease] : Medications (0) | 2020.12.08 |
협심증 증상 특징, Angina pectoris, clinical features (0) | 2020.11.15 |
안정형 협심증에서 칼슘통로차단제 사용, Calcium channel blockers(CCBs) for stable angina pectoris (0) | 2019.05.05 |
안정형 협심증에서 항협심증 약물과 단일 약물로 증상이 지속되는 흉통 (0) | 2019.05.05 |